Project Grant 60NANB24D147

Award Date 10/1/24
Completion Date 9/30/26
Dollars Obligated $963K
Federal Grant Program
11.617
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
This $1,444,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to develop new cryogenic electron microscopy (cryo-EM) methods to visualize the heterogeneity of ribosomes at single-molecule resolution in cells. The principal investigator, a postdoctoral researcher, will pursue strategies to extend a technique called 2D template matching (2DTM) to detect and characterize smaller macromolecular...
The National Institutes of Health (NIH) awarded Arizona State University (ASU) a $1,999,997 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to enhance the university's cryogenic electron microscopy (cryo-EM) capabilities. The funding will enable ASU to acquire an electron energy filtering system and new direct electron detector camera to upgrade their existing cryo-EM instrument. This equipment will improve the resolution and data quality of cryo-EM imaging, benefitting...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $349,999 to Denovx, LLC, a for-profit limited liability company, to adapt the company's surface science expertise to improving specimen preparation for cryogenic electron microscopy (cryo-EM). The goal of this Phase I research is to identify physical and chemical modifications to gold- and carbon-based cryo-EM specimen...
The National Institute of General Medical Sciences (NIGMS) awarded a $344,400 Project Grant (CFDA 93.859 Biomedical Research and Research Training) to The University of Texas Southwestern Medical Center to develop new tools and approaches to enhance cryo-electron microscopy (cryo-EM) and cryo-electron tomography (cryo-ET) imaging techniques. The objectives are to (1) reduce electron-induced radiolysis of frozen-hydrated biological specimens to improve the resolution of cryo-EM/ET images and/or...
This $276,000 Project Grant award from the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support the development of a novel graphene-based grid system to overcome challenges with the air-water interface during cryo-electron microscopy (cryo-EM) sample preparation. The Scripps Research Institute, a nonprofit biomedical research organization, will lead this project to create a...
The National Institute of Standards and Technology (NIST) awarded a $1,140,000 Project Grant under the Congressionally-Identified Projects program (CFDA 11.617) to the West Virginia University (WVU) Research Corporation. The grant will fund the acquisition of a suite of 12 instrumentation tools for WVU's Electron Microscopy Facility (EMF), which will replace obsolete equipment and enhance WVU's shared research capabilities. The new instruments will support advanced materials characterization...
This $1,200,000 Project Grant award from the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074) supports the development and application of a time-resolved cryo-electron microscopy (cryo-EM) method to study the dynamics of diverse biological molecules. The principal investigator and their team at Columbia University will use newly designed PDMS-based microfluidic chips to rapidly mix and freeze biological samples, enabling the capture of intermediate conformational...
The National Institute of Standards and Technology (NIST) awarded a $963,000 Project Grant (CFDA 11.617 - Congressionally-Identified Projects) to San Diego State University (SDSU) to purchase a new Transmission Electron Microscope (TEM) with cryogenic imaging capabilities. The funding will enable SDSU to replace an obsolete TEM instrument and significantly enhance its biological, chemical, and engineering research capabilities. The new TEM will provide access to advanced analytical tools for...
This $963,000 Project Grant award from the National Institute of Standards and Technology's (NIST) Congressionally-Identified Projects (CFDA 11.617) program is intended to fund the procurement of key equipment and data libraries to support the Center for Innovative Drug Discovery (CIDD) at the University of Texas Health Sciences Center at San Antonio (UTHSCSA). The acquired capabilities, which include a cryo-electron microscope, molecular interaction characterization tools, and cell/tissue...
This Cooperative Agreement award from the National Institute of Standards and Technology (NIST) under the Measurement and Engineering Research and Standards (CFDA 11.609) Federal Grant Program provides $7,897,067.09 in funding to the University of Maryland, College Park (UMD) from October 1, 2024 to September 30, 2029. The purpose of this award is to support the advancement of bioscience research activities at the Institute for Bioscience and Biotechnology Research (IBBR), a joint research...

The National Institute of Standards and Technology (NIST) awarded a $963,000 Project Grant under the Congressionally-Identified Projects program (CFDA 11.617) to the University of Maryland, Baltimore (UMB) for the period of October 1, 2024 to September 30, 2026. The purpose of this grant is to accelerate structure-based drug and vaccine design programs that benefit human health by implementing state-of-the-art electron detection hardware to determine 3D structures of various biological compounds at atomic resolution using cryogenic electron microscopy (cryoEM). Specifically, UMB will upgrade its high-resolution cryoEM with a direct electron detector to enable faster detection speed, improved spatial resolution, better stability, and increased radiation hardness. This will significantly improve throughput for imaging and tomographic studies to support numerous biomedical applications, including the optimization of a new class of anticancer agents, examination of the vitamin A transporter STRA6, and collaboration with industry partners to bring new discoveries to the clinical level and improve biomanufacturing protocols. The primary beneficiary of this effort is human health through the development, optimization, and implementation of diverse drugs, proteins, and other biomolecules for therapeutics, vaccines, and modern/preventive medicines.

Generated 6/17/25, 4:18 AM